Healthcare
Healthcare industry stories covering stocks, pharma trends, medical AI, and physician networks backed by real data.
$150B NVO Stock: How One Pill Changes Everything
Healthcare • Obesity • GLP-1 Drugs • Pharma • Turnaround Stocks • Weight Loss
For the first time, a pill can treat obesity. Wegovy tablets launched at 70,000 pharmacies. Phase 3 trials showed 16.6% weight loss. One billion people have obesity. Fewer than 10% will get treatment by 2030. The barrier was never the science. It was the delivery.
The GLP-1 market is projected to reach $150 billion by 2030. No needles. No refrigeration. No weekly injections. The delivery changed. The adoption follows.
500X GH Stock: $80B Market No One Saw Coming
Healthcare • Diagnostics • Liquid Biopsy • Cancer Screening • MedTech • Growth Stocks
Every year 53,000 Americans die from colorectal cancer. Most deaths are preventable. The problem is that 41% of eligible adults skip screening entirely. Colonoscopies are invasive. Stool tests are unpleasant. So people defer, delay, and die. Shield is a blood test. One tube at a routine visit. Patient compliance exceeds 90%. The barrier was never detection. It was behavior.
GH stock surged 226% in 2025. Shield reached $100 million run rate in 12 months. The TAM is $80 billion. Convenience unlocks compliance. Compliance saves lives.
90% Margin: Why DOCS Stock Hit Bottom
Healthcare • Investing • AI • Stock Analysis
Doximity owns 80% of verified US physicians and posts 90% gross margins with 60% Adjusted EBITDA. The stock dropped 46% from its February high after Q2 FY26 beat estimates by 16% but guidance disappointed. Meanwhile, pharma is shifting from rep-led to 80% digital engagement, and Doximity just integrated medicine's largest AI dataset into the only HIPAA-compliant physician platform.
When 80% of verified doctors use your HIPAA-compliant platform and pharma shifts to 80% digital engagement, a 46% stock drop prices in a future that won't arrive.